The Longevity Industry Has a Trust Problem

Longevity needs better filters, fewer miracle claims and a lot more honesty.

There is a version of the longevity movement that I love.

It is curious. It is humble. It is rooted in science, prevention, better habits, earlier detection and the simple but profound idea that we should not wait until we are sick to care about our health.

Then there’s the other version.

The version that promises “age reversal” after a blood test.
The version that sells a $1,000 IV drip as a shortcut to vitality.
The version that turns a preliminary mouse study into a human miracle cure.
The version that implies, subtly or explicitly, that aging has already been solved and that all you need is the right clinic, supplement stack, peptide, plasma infusion, biological age test or “optimization protocol.”

That version has a trust problem.

And if the longevity industry doesn’t fix it, the people who suffer most will be the consumers who came to this movement for the right reasons: to live longer, healthier, more capable lives.

This is also one of the reasons I co-founded Workup⁠. The consumer health market is exploding with new clinics, diagnostics, products, protocols and wellness solutions. Some are thoughtful and evidence-informed. Some are speculative. Some are noise. And some, frankly, veer into snake oil.

Workup was created to help consumers filter signal from noise - to find trusted health and wellness solutions without having to become a full-time researcher, biohacker or skeptic just to make basic decisions about their own body.

Because in longevity, trust is not a nice-to-have.

It’s the whole game.

The Science Is Real. The Claims Often Aren’t.

Aging biology is one of the most exciting fields in science.

Researchers have identified major biological processes associated with aging, including genomic instability, mitochondrial dysfunction, cellular senescence, altered nutrient sensing and chronic inflammation.

But here is where things get slippery: identifying mechanisms of aging is not the same as proving that a consumer product, clinic protocol or supplement meaningfully extends human healthspan.

There is a big difference between:

“This pathway appears to be involved in aging.”

and

“This expensive intervention will make you biologically younger.”

The first statement is science.
The second is often marketing wearing a lab coat.

This is where the longevity industry loses me. Not because I’m skeptical of longevity science. Quite the opposite. I care about this field too much to watch it get diluted by exaggerated claims.

Clinics Are Selling Certainty Where There Is Still Uncertainty

Walk into the modern “optimization” ecosystem and you can find almost anything: NAD+ IVs, stem cell injections, peptide cocktails, hyperbaric oxygen, biological age testing, hormone protocols and full-body scans bundled into executive longevity packages.

Some of these tools have legitimate medical uses in specific contexts. Some may eventually prove useful. Some are simply unproven. Others may be risky when marketed outside appropriate clinical oversight.

A glossy clinic website can make something feel established. A physician founder can make it feel legitimate. A celebrity testimonial can make it feel safe.

But credibility shouldn’t come from branding. It should come from evidence.

The question shouldn’t be, “Does this sound cutting-edge?”

The question should be, “Has this been shown in well-designed human studies to improve outcomes that matter?”

Energy. Strength. Cognition. Metabolic health. Disease risk. Function. Mortality. Quality of life.

Not just a biomarker.
Not just a before-and-after dashboard.
Not just a “biological age” number that drops after a protocol.

The Biological Age Trap

I understand the appeal of biological age testing.

Who wouldn’t want a single number that tells them whether their body is aging faster or slower than the calendar?

But we should be careful. Biomarkers of aging are a promising research area and they may eventually become useful clinical tools. Researchers are actively studying clocks based on DNA methylation, blood markers, proteins, organ-specific aging patterns and other measures.

The problem is not the research.

The problem is when a complex, evolving scientific tool gets turned into a consumer scoreboard.

Your biological age score may be interesting. It may be directionally useful. It may help motivate behavior change. But it is not yet a perfect receipt for how long you will live, nor is it proof that a product has reversed aging.

There is a dangerous psychological trick here: when something is measurable, we assume it is meaningful.

But not everything that moves a metric changes a life.

Special Thanks to Our Partners

This post is sponsored by Nelly’s Organics, a brand I genuinely love and consume constantly.

I’m an avid consumer of their products, especially their Peanut Butter Quinoa bar, which has become part of my daily routine. Most days, I eat one to two bars a day. They are organic, vegan, gluten-free and made with simple ingredients, with 10g of protein, 5g of fiber, and 7g of sugar per bar.

What I appreciate about Nelly’s is that it’s real, convenient, satisfying food that fits into a life where I am trying to make better choices consistently.

You can learn more at NellysOrganics.com⁠.

Supplements: Helpful Sometimes, Overhyped Often

Supplements are another place where the trust problem shows up.

To be clear, I am not anti-supplement. I take supplements. Many people benefit from targeted supplementation, especially when there is a deficiency, a specific health goal or a clinician-guided reason.

But the supplement industry has a structural problem: in the U.S., dietary supplements are generally not approved by the FDA for safety and effectiveness before they are marketed. Companies are responsible for ensuring their products are safe and properly labeled.

That creates room for responsible brands.

It also creates room for inflated promises.

The words are usually carefully chosen:

“Supports healthy aging.”
“Promotes cellular vitality.”
“Activates longevity pathways.”
“Boosts mitochondrial function.”
“Reverses biological age.”

Some of those statements may be technically legal. Some may be based on early evidence. Some may be directionally plausible.

But consumers often hear something much stronger: “This will help me live longer.”

That is a much higher bar.

And in longevity, the bar should be high.

This is why I so deeply appreciate the work that SuppCo⁠ is doing. The supplement category is one of the hardest places for consumers to know whom to trust. Labels can be confusing. Quality varies. Claims can be vague. And even well-intentioned consumers can end up buying products without knowing whether what is on the label is actually what is in the bottle.

SuppCo brings more transparency and structure to that process through tools like supplement tracking, product search, quality ratings, expert protocols and independent testing initiatives. Its TrustScore system evaluates supplements across quality attributes and they verify products through third-party lab testing and publishes product-level results.

That is the kind of infrastructure this industry needs more of.

Not more hype.
More clarity.

Not more miracle language.
More accountability.

NAD Is a Perfect Example

NAD+ is fascinating biology. It plays a real role in cellular metabolism, energy production and repair processes. NAD levels appear to decline with age, which has made NAD-boosting strategies a major focus of longevity research.

But fascinating biology does not automatically justify every NAD+ IV clinic promising better aging.

Some NAD precursors can raise NAD levels in humans. That doesn’t necessarily mean they extend lifespan, prevent disease or meaningfully improve long-term health outcomes.

This is the pattern across the industry.

The molecule is real.
The mechanism is real.
The marketing leap is the problem.

What Trustworthy Longevity Should Look Like

The longevity industry doesn’t need to become boring.

It needs to become more honest.

Here is what I want to see more of:

Clear distinction between proven, promising and speculative.

Exercise is proven. Sleep matters. Blood pressure control matters. Nutrition matters. Smoking cessation matters. Strength training matters. Social connection matters. Managing ApoB, glucose, visceral fat and cardiorespiratory fitness matters.

Certain drugs, supplements, diagnostics and therapies may be promising.

Others are speculative.

Those categories should not be blurred.

More humility around biomarkers.

A lower biological age score is interesting. A better VO2 max, lower blood pressure, improved insulin sensitivity, lower ApoB, stronger grip strength and better sleep may be more actionable.

More outcome-based evidence.

Show me human data. Show me meaningful endpoints. Show me safety. Show me durability. Show me whether the benefit persists after the intervention stops.

Less miracle language.

No more “reverse aging” unless we are very clear about what is being reversed, in whom, for how long and according to what measure.

More respect for the consumer.

People aren’t stupid. They can handle nuance. In fact, many people are hungry for it.

That is the opportunity I see for this next era of consumer health: not just more access, but better filters. Not just more products, but better standards. Not just more data, but more wisdom about what to do with it.

The Real Longevity Revolution Isn’t a Shortcut

The irony is that the most evidence-based longevity interventions are not very sexy.

Go for a walk after meals.
Lift weights.
Eat mostly whole foods.
Get enough protein and fiber.
Sleep enough.
Build strong relationships.
Avoid smoking.
Drink less alcohol.
Know your blood pressure.
Track the biomarkers that actually matter.
Find a doctor who takes prevention seriously.

These habits don’t trend the way a $1,000 infusion trends.

But they work.

And they compound.

That has become the lens through which I try to view longevity: not as a desperate search for the newest hack, but as a long-term practice of stacking small advantages while staying honest about what we know and what we don’t.

I want the longevity industry to win.

But it will not win by overpromising. It will win by earning trust.

The future of longevity should be ambitious, scientific, accessible and honest.

Because the goal is not to sell people the feeling of control.

The goal is to help people live better, longer - for real.

Yours in Health,

Ryan